dsm-firmenich, a global innovator in health, nutrition, and beauty, has announced the approval of its human milk oligosaccharide (HMO), 2'-O-Fucosyllactose (2'-FL)—commercially known as GLYCARE® 2FL—as a functional ingredient for early life nutrition in India. This regulatory milestone marks a new opportunity to enhance infant health, as well as support HMO innovation in the region, with GLYCARE® 2FL representing dsm-firmenich’s first HMO approval in India. The Food Safety and Standards … [Read more...] about Boost for infant health: India approves dsm-firmenich’s 2′-FL HMO